niryuu/sni-each-converted huggingface dataset:
L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Output: L-asparaginase
Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.
Output: Anastrozole
CONCLUSIONS: Anastrozole may be the causative factor in patients with sclerosing glomerulonephritis.
Output: Anastrozole
Diagnosis of sclerosing glomerulonephritis occurred in this patient during anastrozole use, suggesting a newly defined side effect of anastrozole.
Output: anastrozole
Renal injury due to anastrozole has not been published in the English literature.
Output: anastrozole
We believe that the acute renal failure in our patient was associated with anastrozole.
Output: anastrozole
CASE SUMMARY: A 61-year-old woman with no apparent risk factors for liver injury developed acute hepatitis one week after the final dose of a long-term course of pulse itraconazole therapy (200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk) for onychomycosis.
Output: itraconazole
CONCLUSIONS: Prolonged exposure to itraconazole, administered either continuously or intermittently, may precipitate severe and irreversible hepatotoxic events.
Output: itraconazole
Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis.
Output: itraconazole
Only one case of severe symptomatic hepatitis occurring after pulse therapy with itraconazole for onychomycosis and requiring transplantation has been reported previously.
Output: itraconazole
CONCLUSIONS: Intrathecal baclofen can impair sexual function and ejaculation in some patients.
Output: baclofen
RESULTS: A male and a female patient with spasticity treated with intrathecal baclofen were recognized to have sexual dysfunction side effects from treatment.
Output: baclofen
Sexual dysfunction associated with intrathecal baclofen use: a report of two cases.
Output: baclofen
Anaphylactic reaction to recombinant insulin-like growth factor-I.
Output: recombinant insulin-like growth factor-I
We report a 13 year-old male who developed life-threatening anaphylaxis early in the course of Increlex therapy.
Output: Increlex
Increasing the olanzapine dosage severely aggravated the symptoms of RLS.
Output: olanzapine
The fourth patient showed RLS symptoms that were initially caused by a 20-mg daily olanzapine dosage and were later mitigated when olanzapine was reduced and ropinirole was administered.
Output: olanzapine
The second patient exhibited sudden PLMS following olanzapine injection.
Output: olanzapine
Nodular scleritis following alendronate therapy.
Output: alendronate
PURPOSE: To report a case of nodular scleritis following alendronate sodium.
Output: alendronate sodium
Two weeks following rechallenge with alendronate sodium resulted in recurrence of his scleritis.
Output: alendronate sodium
In addition, there is a report on prolonged ECT seizure related to ciprofloxacin, which has an epileptogenic property with a similar action to beta-lactam antibiotics.
Output: ciprofloxacin
Acute delirium resulting from levofloxacin therapy is an exceedingly rare complication that has been thought to occur more commonly in elderly patients.
Output: levofloxacin
Here, we describe levofloxacin-induced delirium with psychotic features in a relatively young, otherwise healthy female.
Output: levofloxacin
Levofloxacin-induced delirium with psychotic features.
Output: Levofloxacin
RESULTS: A previously healthy 42-year-old woman presented with acute-onset delirium with psychotic features as a consequence of levofloxacin therapy.
Output: levofloxacin
CONCLUSIONS: Clinicians should be aware that Crohn's disease is a potential novel adverse drug effect of Copaxone.
Output: Copaxone
Development of Crohn's disease in a patient with multiple sclerosis treated with copaxone.
Output: copaxone
She had been on Copaxone 20 mg/day treatment for 2 years when she first exhibited gastrointestinal symptoms.
Output: Copaxone
The authors present a case study of a mentally healthy man who repeatedly experienced short-lived, obsessional-like suicidal ideas and images after ingestion of the anti-fungal drug ketoconazole.
Output: ketoconazole
Terlipressin-induced ventricular arrhythmia.
Output: Terlipressin
Spontaneous nasal septal perforation with antiangiogenic bevacizumab therapy.
Output: bevacizumab
This case describes a 52-year-old white woman who developed a spontaneous nasal septal perforation after given the antiangiogenic drug, bevacizumab, for metastatic ovarian cancer treatment.
Output: bevacizumab
A 37-year-old woman with relapsing invasive vertebral aspergillosis received intravenous VRC and developed angio-oedema 10 days after starting therapy.
Output: VRC
Angio-oedema as an unusual tolerable side effect of voriconazole therapy.
Output: voriconazole
Here, we report a case of angio-oedema associated with VRC therapy.
Output: VRC
To our knowledge, this is the first report of an angio-oedema associated with VRC.
Output: VRC
Multiple seizures after bupropion overdose in a small child.
Output: bupropion
We report a case of pediatric bupropion ingestion resulting in multiple seizures.
Output: bupropion
Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
Output: Methylphenidate
This is a case report of possible association of methylphenidate and enuresis in an 11-year-old boy with attention deficit hyperactivity disorder.
Output: methylphenidate
Cephalosporin-induced leukopenia following rechallenge with cefoxitin.
Output: Cephalosporin
CONCLUSIONS: Cefazolin was a probable cause of this patient's leukopenia.
Output: Cefazolin
OBJECTIVE: To describe a case of cefazolin-induced leukopenia in a critically ill patient who developed this adverse reaction upon rechallenge with cefoxitin.
Output: cefazolin
Use of the Naranjo probability scale determined the association between cephalosporin use and leukopenia to be probable.
Output: cephalosporin
Stuttering priapism complicating warfarin therapy in a patient with protein C deficiency.
Output: warfarin
This therapy was also complicated by Warfarin-induced skin necrosis.
Output: Warfarin
The patient expired after seven cycles of treatment had been completed because of pulmonary fibrosis and the drug toxicity of bleomycin.
Output: bleomycin
CASE SUMMARY: An 80-year-old white female, followed up at the Memory Clinic for mild cognitive impairment, had been taking propafenone 900 mg/d for >10 years for paroxysmal atrial fibrillation without adverse effects.
Output: propafenone
CONCLUSIONS: Clinicians should be aware of this adverse reaction when facing similar complex neurologic symptoms in patients who are receiving the antibiotic treatment described here, especially vancomycin.
Output: vancomycin
Based on the Naranjo algorithm, the adverse reaction observed was probably related to the hydroxyurea treatment (score = 6); however, the hydroxyurea chemotherapy could not be discontinued because of the myeloproliferative disorder.
Output: hydroxyurea
It is the first case of ciprofloxacin-induced VBDS successfully treated with tacrolimus.
Output: ciprofloxacin
Disseminated salmonellosis in a patient treated with temozolomide.
Output: temozolomide
We describe the first case of disseminated salmonellosis in a patient treated with temozolomide.
Output: temozolomide
Ceftriaxone-induced fixed drug eruption: first report.
Output: Ceftriaxone
We report the first case of a 54-year-old Turkish woman who presented with ceftriaxone-induced FDE.
Output: ceftriaxone
CONCLUSION: All doctors need to be aware of the need to review the indications for gabapentin use during periods of acute illness, especially with regard to renal impairment.
Output: gabapentin
Gabapentin toxicity in renal failure: the importance of dose adjustment.
Output: Gabapentin
OBJECTIVE: This case report outlines a significant type of morbidity due to continued use of gabapentin during an episode of acute renal failure.
Output: gabapentin
Acute syphilitic posterior placoid chorioretinitis following intravitreal triamcinolone acetonide injection.
Output: triamcinolone acetonide
CONCLUSIONS: The fundus picture shown in these cases may be typical of ASPPC after IVTA injection.
Output: IVTA
RESULTS: Two patients with ocular inflammation of unknown origin developed severe chorioretinitis after IVTA injection.
Output: IVTA
Although it is difficult to solely attribute intratumoral hemorrhage to aspirin, we have to be careful when prescribing aspirin for patients who have asymptomatic meningioma.
Output: aspirin
Hemorrhage from a falx meningioma after internal use of low-dose aspirin.
Output: aspirin
On the other hand, aspirin may have promoted the enlargement of spontaneous hemorrhage from meningioma.
Output: aspirin
Our case is the second one in which hemorrhage from a meningioma may have been induced by aspirin prophylaxis.
Output: aspirin
We report a case in which hemorrhage occurred in an asymptomatic falx meningioma known beforehand, after the internal use of low-dose aspirin for 16 months.
Output: aspirin
Acute coronary syndromes can be associated with the infusion of rituximab.
Output: rituximab
Acute coronary syndromes complicating the first infusion of rituximab.
Output: rituximab
The aim of this study was to describe the occurrence of acute coronary syndromes in 3 cases of rituximab infusions.
Output: rituximab
The occurrence of symptoms that could be ascribed to an acute coronary syndrome should always be taken seriously during the first rituximab infusion and investigated aggressively.
Output: rituximab
We reviewed the records of 3 patients with lymphoproliferative disorders who experienced acute coronary syndromes associated with their initial infusion of rituximab.
Output: rituximab
Adrenal suppression in a fetus due to administration of methylprednisolone has hitherto been rarely published.
Output: methylprednisolone
CONCLUSIONS: Life-threatening adrenal suppression, requiring hydrocortisone supplementation and intensive therapy, was observed and successfully treated in a newborn, whose mother had received high-dose methylprednisolone in late pregnancy.
Output: methylprednisolone
High-dose methylprednisolone in a pregnant woman with Crohn's disease and adrenal suppression in her newborn.
Output: methylprednisolone
When DSCG was withdrawn, urticaria vanished and the child remained symptom-free.
Output: DSCG
Syncope induced by propranolol in hypertrophic cardiomyopathy.
Output: propranolol
Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.
Output: Leflunomide
Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy.
Output: etanercept
This is an image and brief case report of a 13-year-old boy who presented with severe rash and systemic symptoms after starting oxcarbazepine.
Output: oxcarbazepine
After treatment with a beta-sympathomimetic drug (Partusisten) one fetus developed supraventricular tachycardia.
Output: Partusisten
Rosaceiform eruption induced by erlotinib.
Output: erlotinib
The aim of this paper is to report the case of rosaceiform eruption induced by erlotinib in an 81-year-old-man and to discuss the pathogenetic role of Demodex folliculorum mites, found in the present patient, using skin scraping.
Output: erlotinib
In patients with methotrexate-induced anaphylaxis, discontinuation of treatment may increase the risk of death due to cancer progression.
Output: methotrexate
Management and successful desensitization in methotrexate-induced anaphylaxis.
Output: methotrexate
Thus, we confirm that desensitization may be a safe procedure in patients with cancer who experience methotrexate-induced anaphylaxis.
Output: methotrexate
We report the case of a child with metastatic osteosarcoma, who experienced an anaphylactic/anaphylactoid reaction to methotrexate.
Output: methotrexate
Drug-induced fever due to diltiazem.
Output: diltiazem
Drug-induced fever should be considered in patients who have unexplained high temperatures during diltiazem therapy.
Output: diltiazem
To our knowledge, drug-induced fever has not been reported with the use of diltiazem hydrochloride, a commonly prescribed calcium channel blocker.
Output: diltiazem hydrochloride
A case of congestive heart failure in a child with Wilms' tumor treated Adriamycin is presented and discussed.
Output: Adriamycin
Radiologic recognition of adriamycin cardiotoxicity.
Output: adriamycin
The role of Adriamycin in the production of cardiotoxicity is reviewed.
Output: Adriamycin
Carbamazepine-induced Diabetes mellitus.
Output: Carbamazepine
Diabetes Mellitus was observed in a patient given carbamazepine.
Output: carbamazepine
Although heparin-dependent antibodies (HDAs) typically manifest with thrombocytopenia as in heparin-induced thrombocytopenia (HIT), they may also manifest with preserved platelet counts.
Output: heparin
Clinicians should be cognizant of this possibility and consider a diagnosis of HDAs in patients with ongoing thrombosis who are receiving heparin therapy.
Output: heparin
Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
Output: heparin
Despite these antithrombotic effects, the patient developed repeated venous thromboembolism during treatment with low-molecular-weight heparin.
Output: heparin
Initiation of posaconazole led to clinical improvement until the patient's demise from bacteremic vancomycin-resistant enterococcal peritonitis.
Output: posaconazole
Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir.
Output: triamcinolone
We report the first case of a human immunodeficiency virus type 1 (HIV-1)-infected individual receiving combination antiretroviral therapy, which included ritonavir, who developed Cushing syndrome with profound complications after epidural triamcinolone injections.
Output: triamcinolone
A 22-year-old drug-abuser injected flunitrazepam tablets dissolved in tap water into her left femoral artery and presented with clinical signs of acute ischaemia of the left leg.
Output: flunitrazepam
Acute ischaemia of the leg following accidental intra-arterial injection of dissolved flunitrazepam tablets.
Output: flunitrazepam
A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma.
Output: lenalidomide
Although moderate myelosuppression is not uncommonly seen in patients treated with lenalidomide, aplastic anemia has not previously been reported to be associated with this agent.
Output: lenalidomide
After cessation of amantadine, the edema resolved, and the endothelial cell densities were <or=600/mm.
Output: amantadine
CONCLUSIONS: Amantadine can cause reversible corneal edema but can irreversibly reduce the density of endothelial cells.
Output: Amantadine
Corneal edema recurred when the administration of amantadine was resumed.
Output: amantadine
Corneal endothelial dysfunction associated with amantadine toxicity.
Output: amantadine
PURPOSE: To describe bilateral corneal endothelial dysfunction in a patient with Parkinson disease who was treated with long-term amantadine.
Output: amantadine
RESULTS: A 52-year-old woman with Parkinson disease who had taken amantadine for 6 years had bilateral corneal edema for 2 months at baseline.
Output: amantadine
Therefore, amantadine was permanently discontinued and the cornea cleared again.
Output: amantadine
Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: a class effect?
Output: sunitinib
We report the first biopsy confirmed occurrence of acute interstitial nephritis in a patient receiving treatment with Sunitinib for metastatic renal cell cancer.
Output: Sunitinib
Extrapyramidal symptoms are well-documented complications of therapy with haloperidol, even when small doses are used.
Output: haloperidol
This report highlights a case of drug-induced dysphagia in a patient receiving haloperidol for obsessive nocturnal thoughts and auditory disturbances.
Output: haloperidol
A 52 year-old male patient diagnosed of ankylosing spondylitis presented with an iron deficiency anemia after a ten-month treatment of methotrexate.
Output: methotrexate
Methotrexate induced sprue-like syndrome.
Output: Methotrexate
Only 3 cases of imatinib-induced tumor lysis syndrome have been reported.
Output: imatinib
We herein described an additional patient with BCR-ABL (ela2) positive acute lymphoblastic leukemia who developed tumor lysis syndrome after 10-day treatment with imatinib.
Output: imatinib
IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C.
Output: IFNalpha
We report the case of a 51-year-old man in whom IFN-alpha treatment was followed by recurrence of Graves' disease 10 years after thyroidectomy was performed and the patient was declared cured.
Output: IFN-alpha
Interstitial granulomatous dermatitis associated with darifenacin.
Output: darifenacin
The authors describe a case of interstitial granulomatous dermatitis associated with darifenacin.
Output: darifenacin
METHODS: A retrospective report of the first case of gemcitabine-related HUS, in a patient with metastatic pancreatic adenocarcinoma, treated with a variety of standard therapies in addition to rituximab is presented.
Output: gemcitabine
Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report.
Output: gemcitabine
Drug rash with eosinophilia and systemic symptoms after chlorambucil treatment in chronic lymphocytic leukaemia.
Output: chlorambucil
We report the first case of chlorambucil-induced DRESS syndrome in a 70-year-old man recently diagnosed with chronic lymphocytic leukaemia.
Output: chlorambucil
Although his renal function recovered completely with high-dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of renal toxicity may be present as early as 2 hours after the completion of a 4-hour MTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4-hour MTX infusion.
Output: MTX
Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Output: methotrexate
Multifocal electroretinographic abnormalities in ethambutol-induced visual loss.
Output: ethambutol
Tenofovir-associated nephrotoxicity in two HIV-infected adolescent males.
Output: Tenofovir
In this case, discontinuing piroxicam, a nonsteroidal anti-inflammatory drug, and starting a palliative treatment plan helped resolve a patient's ulcers.
Output: piroxicam
Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient.
Output: immunoglobulin
Acute renal failure is a rare complication following the administration of intravenous immunoglobulin (IVIG).
Output: immunoglobulin
The exact mechanism of IVIG-associated acute renal failure remains unclear.
Output: IVIG
A 58-year-old man with advanced renal cell carcinoma developed grade 3 proteinuria (8.5 g/24 h) without microscopic hematuria or renal insufficiency five days after temsirolimus infusion.
Output: temsirolimus
Temsirolimus-induced glomerulopathy.
Output: Temsirolimus
Persistent hypoglycemia in a patient with diabetes taking etanercept for the treatment of psoriasis.
Output: etanercept
We report a patient with type 2 diabetes mellitus who, while treated with the antitumor necrosis factor-alpha blocking agent etanercept for severe plaque psoriasis, experienced persistent hypoglycemia requiring the lowering and eventual elimination of his previous insulin regimen.
Output: etanercept
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is reported in up to 18.6% of patients treated with intravenous bisphosphonates and can result in significant morbidity.
Output: Bisphosphonate
Bisphosphonate-related osteonecrosis of the skull base.
Output: Bisphosphonate
A previous study of patients with "quinine-associated TTP/HUS" found that ADAMTS13 activities were not abnormal in 12/12 patients.
Output: quinine
We recommend that a TMA in association with quinine be consistently referred to as quinine-associated thrombotic microangiopathy (quinine-TMA) to better distinguish this entity from idiopathic TTP.
Output: quinine
Complications associated with primary and secondary perforation of the bladder following immediate instillations of epirubicin after transurethral resection of superficial urothelial tumours.
Output: epirubicin
MATERIALS AND METHODS: We present two cases of significant morbidity related to primary and secondary perforation of the bladder following two instillations of epirubicin.
Output: epirubicin
Aliskiren-associated acute renal failure with hyperkalemia.
Output: Aliskiren
According to the Naranjo et al. adverse-reaction probability scale, enoxaparin was the probable cause of hepatotoxicity in this patient.
Output: enoxaparin
CONCLUSION: A woman receiving enoxaparin every 12 hours developed signs and symptoms of hepatotoxicity after the second dose.
Output: enoxaparin
Probable enoxaparin-induced hepatotoxicity.
Output: enoxaparin
PURPOSE: A case of probable enoxaparin-induced hepatotoxicity is described.
Output: enoxaparin
Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings.
Output: methotrexate
The addition of intrathecal methotrexate to treatment protocols has increased survival rates in children with acute lymphoblastic leukemia but is also associated with varying degrees of neurotoxicity.
Output: methotrexate
We describe a 15-year-old female patient diagnosed with acute lymphoblastic leukemia presenting with status epilepticus after receiving intrathecal methotrexate.
Output: methotrexate
Cyclosporine-induced pain syndrome in a child undergoing hematopoietic stem cell transplant.
Output: Cyclosporine
In this case, CIPS was considered to be probably associated with cyclosporine according to the Naranjo probability scale.
Output: cyclosporine
OBJECTIVE: To report a case of calcineurin-induced pain syndrome (CIPS) in a child undergoing his second hematopoietic stem cell transplant (HSCT).
Output: calcineurin
Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome.
Output: risperidone
This report describes a case of neuroleptic malignant syndrome due to risperidone in a child with Joubert syndrome.
Output: risperidone
The most common complication of warfarin use is adverse bleeding.
Output: warfarin
DISCUSSION: This case shows that switching to zidovudine potentially can lead to a hyperlactatemia relapse.
Output: zidovudine
INTRODUCTION: In resource limited settings patients on antiretroviral treatment who develop stavudine induced hyperlactatemia are often switched to zidovudine on the basis of published studies that demonstrate that this agent can be a safe alternative.
Output: stavudine
Anaphylactic reaction to bacitracin ointment.
Output: bacitracin
We report a case of an 11-year-old boy who experienced an anaphylactic reaction after administration of bacitracin ointment.
Output: bacitracin
Herein, we present a patient with severe and prolonged hypoglycemia after long-acting octreotide treatment.
Output: octreotide
Hypoglycemia induced by long-acting somatostatin analogues in a patient with nonfunctional neuroendocrine tumor.
Output: somatostatin
In these patients, long-acting octreotide may trigger serious hypoglycemia.
Output: octreotide
Leukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine.
Output: azathioprine
The uncomplicated long-term use of adequately-dosed AZA and stable non-toxic metabolite levels could not acknowledge TPMT deficiency as a primary cause of the leukopenia.
Output: AZA
We present the case of an adult Crohn's disease patient with a parvovirus B19 infection and leukopenia during long-term AZA therapy.
Output: AZA
Isoniazid causing breast tissue enlargement has been very rarely reported.
Output: Isoniazid
Isoniazid induced gynaecomastia: a case report.
Output: Isoniazid
Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature.
Output: alemtuzumab
Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
Output: etoposide
The risk of developing sAML is estimated to be between 1% and 5%, 2-20 years after exposure to etoposide but may also be related to cumulative drug doses, treatment schedules, host factors and co-administration of other antineoplastic agents.
Output: etoposide
Polymyoclonus seizure resulting from accidental injection of tranexamic acid in spinal anesthesia.
Output: tranexamic acid
Rhabdomyolysis following clarithromycin monotherapy.
Output: clarithromycin
We report the first case of rhabdomyolysis related to the administration of clarithromycin without concurrent use of other medications.
Output: clarithromycin
However, re-initiation of sunitinib treatment was followed by bilateral breast enlargement again.
Output: sunitinib
Onset of male gynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma.
Output: sunitinib
The mechanism by which sunitinib induces gynaecomastia is thought to be associated with an unknown direct action on breast hormonal receptors.
Output: sunitinib
Divalproex sodium-induced eosinophilic pleural effusion.
Output: Divalproex sodium
Withdrawal of Depakote resulted in resolution of the effusion.
Output: Depakote
Flurbiprofen-associated acute tubulointerstitial nephritis.
Output: Flurbiprofen
We report a case of biopsy-proven acute tubulointerstitial nephritis associated with a second course of flurbiprofen, a nonsteroidal anti-inflammatory drug of the propionic acid class.
Output: flurbiprofen
Stupor and fast activity on electroencephalography in a child treated with valproate.
Output: valproate
The case of a 4-year-old girl with valproate-induced stupor and electroencephalographic pattern of increased fast activity is reported.
Output: valproate
This article presents a case of an atypical localized cutaneous eruption with an unusual course and protracted resolution time associated with sorafenib therapy.
Output: sorafenib
According to the Naranjo adverse drug reaction probability scale, tigecycline was the probable cause of her acute pancreatitis.
Output: tigecycline
Pancreatitis has been associated with the tetracycline class of antibiotics and concerns about tigecycline-induced acute pancreatitis have recently been raised.
Output: tigecycline
Tigecycline-induced acute pancreatitis: case report and literature review.
Output: Tigecycline
We report a case of biopsy proven myositis whose symptoms began within 10 days of receiving leuprolide acetate therapy for prostate cancer.
Output: leuprolide acetate
Aripiprazole-induced hiccups: a case report.
Output: Aripiprazole
We report a patient of organic bipolar affective disorder who developed hiccups with the atypical antipsychotic aripiprazole.
Output: aripiprazole
CONCLUSIONS: This patient's rhabdomyolysis was probably induced by sertraline therapy.
Output: sertraline
DISCUSSION: The Naranjo probability scale indicated a probable relationship between sertraline treatment and the onset of rhabdomyolysis.
Output: sertraline
OBJECTIVE: To describe a case of sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities.
Output: sertraline
Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities.
Output: Sertraline
The patient's other comorbidities and medications have not been suggested as possible interactions with sertraline that can cause rhabdomyolysis.
Output: sertraline
Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma.
Output: cisplatin
He had priapism following the use of olanzapine.
Output: olanzapine
Priapism associated with olanzapine.
Output: olanzapine
Can ketamine prescribed for pain cause damage to the urinary tract?
Output: ketamine
Possible mechanisms for damage to the urothelium by ketamine are suggested.
Output: ketamine
Presentation of three palliative care patients who were given ketamine as an analgesic and subsequently developed significant and debilitating urological symptoms.
Output: ketamine
Carbamazepine-induced hyperammonemia.
Output: Carbamazepine
CONCLUSION: A 26-year-old man with bipolar disorder developed hyperammonemia three weeks after initiating carbamazepine therapy.
Output: carbamazepine
He had also developed elevated serum ammonia levels while on valproic acid.
Output: valproic acid
PURPOSE: A case of carbamazepine-induced hyperammonemia is presented.
Output: carbamazepine
A case of acute respiratory failure due to diaphragmatic weakness following adalimumab therapy for psoriasis is described.
Output: adalimumab
Acute bilateral phrenic neuropathy following treatment with adalimumab.
Output: adalimumab
CONCLUSIONS: Spontaneous hemothorax is a rare phenomenon in conjunction with LMWH but should be considered in cases of acute respiratory distress following commencement of LMWH.
Output: LMWH
On day 4, following 3 doses of dalteparin, the patient developed acute respiratory distress attributable to a massive right hemothorax confirmed by computed tomography pulmonary angiography (CTPA) and intercostal drainage of 1500 mL of frank blood.
Output: dalteparin
Spontaneous hemothorax following anticoagulation with low-molecular-weight heparin.
Output: heparin
Acute ocular ischemic change may be associated with intravitreal injection of bevacizumab in patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery.
Output: bevacizumab
Three days after intravitreal injection of bevacizumab, acute ocular ischemic syndrome occurred.
Output: bevacizumab
Increased awareness is needed on the possible occurrence of LPD resembling gastric cancer in rheumatoid arthritis patients treated with MTX.
Output: MTX
Reversible methotrexate-associated lymphoproliferative disorder resembling advanced gastric cancer in a patient with rheumatoid arthritis.
Output: methotrexate
To our knowledge, this is the first case of spontaneous remission of MTX-associated gastric LPD after discontinuation of MTX therapy.
Output: MTX
Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient.
Output: Sorafenib
Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope.
Output: oxymetazoline
We report here a case of cardiovascular and neurological depression induced by oxymetalzoline in a toddler.
Output: oxymetalzoline
Given that discontinuation of nitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of toxic liver damage caused by nitrofurantoin.
Output: nitrofurantoin
Nitrofurantoin-induced acute liver damage in pregnancy.
Output: Nitrofurantoin
Primary central nervous system lymphoma in a patient treated with natalizumab.
Output: natalizumab
OBJECTIVE: To report a case of severe apnea in an infant exposed to lamotrigine through breast-feeding.
Output: lamotrigine
Severe apnea in an infant exposed to lamotrigine in breast milk.
Output: lamotrigine
The Naranjo probability scale indicated a probable relationship between apnea and exposure to lamotrigine through breast-feeding in this infant.
Output: lamotrigine
Although there have been numerous reports of effusions, none have provided complete pleural fluid analysis; therefore, we report 2 patients with dasatinib-induced pleural effusion with complete pleural fluid analysis.
Output: dasatinib
Dasatinib-induced pleural effusions: a lymphatic network disorder?
Output: Dasatinib
RESULTS: One case of recurrent primary peritoneal carcinoma previously treated with a carboplatin-based regimen, developed a platinum hypersensitivity.
Output: carboplatin
One week after the initial-dose of adalimumab (160 mg), which was initiated due to an acute exacerbation of Crohn's disease, the patient developed a fulminant cardiomyopathy.
Output: adalimumab
Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease.
Output: adalimumab
Recovery of the tubular dysfunction took 15 days following cessation of the offending drug, Amikacin.
Output: Amikacin
Thrombin is highly effective for stopping intractable arterial hemorrhage during stereotactic brain biopsy; however, it is a vasospastic agent and may have been responsible for the cerebral infarctions in one patient.
Output: Thrombin
Ciprofloxacin-induced hemorrhagic vasculitis.
Output: Ciprofloxacin
Ciprofloxacin-induced hemorrhagic vasculitis is a rare side effect.
Output: Ciprofloxacin
Ciprofloxacin is among the standard treatments for infected ischemic ulcers; in the rare case of ciprofloxacin-induced hemorrhagic vasculitis, it might be interpreted as progression of infection, instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
Output: ciprofloxacin
However, a recent post-marketing survey in Japan revealed that interstitial pneumonia occurred in 4 among approximately 2 000 Japanese patients treated with sorafenib.
Output: sorafenib
Interstitial pneumonia probably associated with sorafenib treatment: An alert of an adverse event.
Output: sorafenib
In this article, we describe a Japanese patient with severe interstitial pneumonia probably caused by sorafenib treatment for metastatic renal cell carcinoma.
Output: sorafenib
Oncologists supervising future clinical trials for lung cancer should be alert to the fact that sorafenib can potentially induce serious interstitial lung disease, although this might depend on racial differences.
Output: sorafenib
Fatal gemcitabine-induced pulmonary toxicity in metastatic   gallbladder adenocarcinoma.
Output: gemcitabine
Gemcitabine-induced pulmonary toxicity is usually a dramatic condition.
Output: Gemcitabine
In this report, we describe a fatal gemcitabine-induced pulmonary toxicity in a patient with gallbladder metastatic adenocarcinoma.
Output: gemcitabine
He had hypokalemia (K 2.3 mmol/L) induced by licorice and also had received disopyramide for arrhythmia, bicalutamide for prostate cancer, and silodosin for prostate hypertrophy.
Output: licorice
Of 371 patients treated with 8MOP, three (0.8%) developed an acute dermatitis in the PUVA-treated areas.
Output: 8MOP
Hepatotoxicity after high-dose methylprednisolone for demyelinating disease.
Output: methylprednisolone
We observed 2 cases of hepatotoxicity after a high-dose methylprednisolone treatment of a demyelinating disease and evaluated the potential relationship in the light of available evidence.
Output: methylprednisolone
Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
Output: Clozapine
However, several case reports have suggested that clozapine could also cause TD.
Output: clozapine
OBJECTIVE: Clozapine causes few extrapyramidal symptoms and is recommended as a treatment drug for severe tardive dyskinesia (TD).
Output: Clozapine
Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?
Output: carboplatin
Hypersensitivity to carboplatin has been reported in up to 44% of patients receiving this antineoplastic agent, usually occurring after several courses of treatment.
Output: carboplatin
Prick tests and intradermal tests with a series of dilutions of carboplatin and cisplatin were performed on three patients who had exhibited medium and severe hypersensitivity reactions to carboplatin.
Output: carboplatin
A patient, while on intravenous ritodrine therapy for preterm labor, experienced an episode of acute chest pain.
Output: ritodrine
Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction.
Output: anthracycline
CONCLUSIONS: We present a case of a patient with CML who developed KS 12 months after starting treatment with imatinib 400 mg/d.
Output: imatinib
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Output: imatinib mesylate
OBJECTIVE: We report a case of cutaneous KS lesions in a patient affected by CML treated with imatinib.
Output: imatinib
Interferon-based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including neuropsychiatric symptoms.
Output: Interferon
Interferon-induced psychosis as a "psychiatric contraindication" to hepatitis C treatment: a review and case-based discussion.
Output: Interferon
OBJECTIVE: The authors described a case of interferon-induced psychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C.
Output: interferon
CONCLUSION: Zidovudine is well a known cause of anaemia and thus should be used with caution in the initiation of antiretroviral therapy.
Output: Zidovudine
Zidovudine induced pure red cell aplasia: a case report.
Output: Zidovudine
PURPOSE: To describe spectral-domain optical coherence tomography (SD-OCT) and adaptive optics (AO) imaging in hydroxychloroquine retinal toxicity.
Output: hydroxychloroquine
Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.
Output: hydroxychloroquine
Transient trazodone-induced hypomanic symptoms occurred in three depressed patients.
Output: trazodone
Trazodone-induced transient hypomanic symptoms and their management.
Output: Trazodone
Introduction of etanercept was also clinically effective but followed by development of severe heart failure.
Output: etanercept
Reversible heart failure in a patient receiving etanercept for ankylosing spondylitis.
Output: etanercept
Combining methylephedrine and Chinese herbal drugs might carry a risk of stroke.
Output: methylephedrine
A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy.
Output: methotrexate
Methotrexate may rarely provoke serositis, even with low doses and after just a few weeks of therapy.
Output: Methotrexate
We report here a rare case of pleuropericarditis due to methotrexate.
Output: methotrexate
Tremor: a newly described adverse event with long-term itraconazole therapy.
Output: itraconazole
Hypersensitivity to zonisamide was confirmed by the skin patch test.
Output: zonisamide
Only two case reports of adults with allergic contact dermatitis to this chemical exist in the literature, and we describe three more cases of children with recalcitrant atopic dermatitis found to have potential allergic contact dermatitis to bisabolol- a component of the Aquaphor emollient they were using to treat their atopic dermatitis.
Output: bisabolol
Case report: acute renal failure after administering intravenous immunoglobulin.
Output: immunoglobulin
The hospital course of the acute renal failure is presented with a review of the literature on cases of acute renal failure after IVIG.
Output: IVIG
Severe vancomycin-induced anaphylactic reaction.
Output: vancomycin
We report a case of a 23-year-old man who developed a vancomycin-induced anaphylactic reaction in the treatment of methicillin-resistant Staphylococcus aureus infection.
Output: vancomycin
Four patients in whom pulmonary oedema developed during tocolysis with hexoprenaline are described and the aetiological factors and pathogenesis of this potentially lethal complication discussed.
Output: hexoprenaline
Pulmonary oedema after hexoprenaline administration in preterm labour.
Output: hexoprenaline
Fatal interstitial lung disease after erlotinib administration in a patient with radiation fibrosis.
Output: erlotinib
High-resolution computed tomography scan findings were consistent with ILD, which was sufficient to diagnose as erlotinib-induced ILD.
Output: erlotinib
RESULTS: We recently experienced a case of fatal erlotinib-induced ILD, diagnosed based on clinical and radiologic findings, which occurred in a patient with radiation fibrosis.
Output: erlotinib
This case had radiation fibrosis, so we suggest that radiation fibrosis may be another contributor of the occurrence of ILD in patients taking erlotinib.
Output: erlotinib
One patient suffered coronary artery vasospasm, attributed to the use of topical 1:1000 epinephrine during surgery.
Output: epinephrine
The other patient developed transient intraoperative hypertension immediately after inadvertent submucosal injection of concentrated epinephrine.
Output: epinephrine
However, to our knowledge, in newborns there have been no reported cases to date of thrombocytosis induced by enoxaparin.
Output: enoxaparin
Thrombocytosis associated with enoxaparin: A very rare cause in newborns.
Output: enoxaparin
Thrombocytosis induced by enoxaparin has been reported as a rare adverse effect of this medication in adults.
Output: enoxaparin
Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.
Output: hydroxychloroquine
Due to the increasing use of TMP-SMX in children, clinicians should be aware of this potentially life-threatening, immunemediated hypersensitivity reaction.
Output: TMP-SMX
Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
Output: Trimethoprim-sulfamethoxazole
Use of the Naranjo adverse drug reaction probability scale indicated a probable relationship (score of 5) between the patient's development of hepatotoxicity and the TMP-SMX therapy.
Output: TMP-SMX
We describe a relatively healthy, 9-year-old boy who developed a CA-MRSA skin and soft tissue infection and was treated with TMP-SMX.
Output: TMP-SMX
Amiodarone was discontinued, and thyrotoxicosis gradually abated.
Output: Amiodarone
BACKGROUND: Aphthous stomatitis, a common mucocutaneous disorder, is a well accepted complication of sirolimus therapy.
Output: sirolimus
Severe aphthous stomatitis associated with oral calcineurin and mTOR inhibitors.
Output: calcineurin
These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal-change nephrotic syndrome, may be responsible for the MP-induced transient renal failure.
Output: MP
A 67-year-old patient, with primary polymyositis and without previous evidence of liver disease, developed clinical and biochemical features of severe cholestasis 3 months after initiation of azathioprine therapy.
Output: azathioprine
It is believed that this is the first reported case of reversible azathioprine-induced cholestasis associated with histological evidence of bile duct injury.
Output: azathioprine
A case of the Rett syndrome with acute encephalopathy induced during calcium hopantenate treatment.
Output: calcium hopantenate
Persistent light reactivity from systemic quinine.
Output: quinine
The photosensitivity is still present 3 years after the withdrawal of quinine.
Output: quinine
A patient with Wegener's granulomatosis rapidly developed a circumferential subglottic stenosis while on a cyclophosphamide regimen that had caused resolution of systemic symptoms and pulmonary infiltrates.
Output: cyclophosphamide
Subglottic stenosis in Wegener's granulomatosis: development during cyclophosphamide treatment with response to carbon dioxide laser therapy.
Output: cyclophosphamide
A case is described of severe splenic hemorrhage and rupture which developed 3 h after completion of tPA infusion for suspected acute myocardial infarction.
Output: tPA
Splenic hemorrhage: a complication of tissue plasminogen activator treatment.
Output: tissue plasminogen activator
A case of severe acute hepatitis caused by cyproterone acetate in a 71 year old man with prostatic carcinoma is reported with a review of the literature on hepatic reactions to this drug.
Output: cyproterone acetate
Monitoring of liver function tests should be mandatory in patients receiving high doses of cyproterone acetate; the drug should be withdrawn immediately if abnormal liver function tests are found.
Output: cyproterone acetate
Severe hepatitis caused by cyproterone acetate.
Output: cyproterone acetate
A unique case of a transient, nonpigmenting fixed drug eruption caused by the radiopaque contrast medium iothalamate is reported.
Output: iothalamate
One patient with systemic lupus erythematosus developed erythema multiforme after taking griseofulvin.
Output: griseofulvin
Aminoglutethimide was discontinued until completion of radiotherapy, and the rash resolved.
Output: Aminoglutethimide
Concomitant irradiation apparently enhanced the skin toxicity of aminoglutethimide or possibly aminoglutethimide had a radiosensitizing role in this patient.
Output: aminoglutethimide
We report a case of radiotherapy-enhanced aminoglutethimide skin toxicity in a patient with metastatic breast cancer.
Output: aminoglutethimide
Data have been published regarding the possibility that tamoxifen may be responsible for the subsequent development of carcinoma of the corpus uteri in these patients.
Output: tamoxifen
The authors intend to carry out a case-control study on patients treated with tamoxifen for breast carcinoma to reveal the possible presence of endometrial carcinoma.
Output: tamoxifen
Disulfiram-induced hepatitis.
Output: Disulfiram
We reported a case of disulfiram-induced hepatitis with unique clinical features and compared our case with others in the literature.
Output: disulfiram
Methotrexate-induced leukoencephalopathy is treatable with high-dose folinic acid: a case report and analysis of the literature.
Output: Methotrexate
We report a patient who developed heparin associated thrombocytopenia during continuous arteriovenous haemofiltration and discuss its implications and alternative anticoagulant treatment.
Output: heparin
Acute aluminum toxicity after continuous intravesical alum irrigation for hemorrhagic cystitis.
Output: alum
Awareness of this route of intoxication might be important in patients in whom neurologic or psychiatric symptoms develop while large amounts of lidocaine cream are being used.
Output: lidocaine
Nitrendipine-induced gingival hyperplasia.
Output: Nitrendipine
Nitrendipine is an experimental calcium channel blocking agent that also appears to cause the side effect of drug-induced gingival hyperplasia.
Output: Nitrendipine
Physicians using this "new" drug must be aware of the potential danger of sulfonamide-induced injury to the urinary tract.
Output: sulfonamide
Sulfadiazine crystalluria revisited.
Output: Sulfadiazine
Glaucoma secondary to epithelial downgrowth and 5-fluorouracil.
Output: 5-fluorouracil
We report a case of secondary glaucoma caused by epithelial downgrowth in which filtration surgery was performed with adjunctive use of subconjunctival 5-fluorouracil.
Output: 5-fluorouracil
Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature.
Output: sucralfate
Acute coronary events following cisplatin-based chemotherapy.
Output: cisplatin
Bowel perforation associated with intraperitoneal chromic phosphate instillation.
Output: chromic phosphate
Delayed bowel injury is an infrequently observed complication of chromic phosphate administration.
Output: chromic phosphate
This report presents a case of colon perforation which occurred 4 months after treatment with intraperitoneal chromic phosphate for stage IB ovarian papillary serous cystadenocarcinoma.
Output: chromic phosphate
Bromide intoxication secondary to pyridostigmine bromide therapy.
Output: pyridostigmine bromide
To our knowledge , this is the first reported case of bromide intoxication due to pyridostigmine bromide administration.
Output: pyridostigmine bromide
Diazepam use by pregnant women can be associated with a later presentation of withdrawal symptoms in the neonate than that induced by the use of other drugs.
Output: Diazepam
We conclude that neurosurgeons and neurologists should be aware of calcium antagonist--related ileus in patients treated with nimodipine.
Output: nimodipine
After discontinuation of danazol the diabetes completely resolved.
Output: danazol
Insulin-dependent diabetes mellitus associated with danazol.
Output: danazol